Literature DB >> 32222370

Association of Cardiovascular Mortality and Deep Learning-Funduscopic Atherosclerosis Score derived from Retinal Fundus Images.

Jooyoung Chang1, Ahryung Ko2, Sang Min Park3, Seulggie Choi1, Kyuwoong Kim1, Sung Min Kim1, Jae Moon Yun2, Uk Kang4, Il Hyung Shin5, Joo Young Shin6, Taehoon Ko7, Jinho Lee8, Baek-Lok Oh8, Ki Ho Park8.   

Abstract

PURPOSE: The prediction of atherosclerosis using retinal fundus images and deep learning has not been shown possible. The purpose of this study is to develop a deep learning model which predicts atherosclerosis using retinal fundus images and to verify its clinical implications by conducting a retrospective cohort analysis.
DESIGN: Retrospective cohort study.
METHODS: The database at Health Promotion Center of Seoul National University Hospital (HPC-SNUH) was used. The deep learning model was trained on 15,408 images to predict carotid artery atherosclerosis, which we named the deep learning-funduscopic atherosclerosis score (DL-FAS). We constructed a retrospective cohort of participants aged 30-80 years who had completed elective health check-ups at HPC-SNUH. Using DL-FAS the as the main exposure, we followed participants for the primary outcome of death due to CVD until Dec. 31st, 2017.
RESULTS: For predicting carotid artery atherosclerosis among testing-set subjects, the model achieved an AUROC, AUPRC, accuracy, sensitivity, specificity, positive predictive value, and negative predictive value of 0.713, 0.569, 0.583, 0.891, 0.404, 0.465, and 0.865 respectively. The cohort comprised of 32,227 participants, 78 CVD deaths, and 7.6-year median follow-up. Those with DL-FAS greater than 0.66 had an increased risk of CVD deaths compared to DL-FAS<0.33 (HR, 95%CI; 8.83, 3.16-24.7). Risk association was significant among intermediate and high Framingham risk score (FRS) subgroups. The DL-FAS improved the concordance by 0.0266 (95% CI, 0.0043-0.0489) over the FRS-only model. Relative integrated discrimination index (IDI) was 20.45% and net reclassification index (NRI) was 29.5%.
CONCLUSIONS: We developed a deep learning model which can predict atherosclerosis from retinal fundus images. The resulting DL-FAS was an independent predictor of CVD deaths when adjusted for FRS and added predictive value over FRS.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32222370     DOI: 10.1016/j.ajo.2020.03.027

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

Review 1.  Artificial Intelligence in Predicting Systemic Parameters and Diseases From Ophthalmic Imaging.

Authors:  Bjorn Kaijun Betzler; Tyler Hyungtaek Rim; Charumathi Sabanayagam; Ching-Yu Cheng
Journal:  Front Digit Health       Date:  2022-05-26

Review 2.  Hypertensive eye disease.

Authors:  Carol Y Cheung; Valérie Biousse; Pearse A Keane; Ernesto L Schiffrin; Tien Y Wong
Journal:  Nat Rev Dis Primers       Date:  2022-03-10       Impact factor: 52.329

3.  Multiple instance learning detects peripheral arterial disease from high-resolution color fundus photography.

Authors:  Simon Mueller; Maximilian W M Wintergerst; Peyman Falahat; Frank G Holz; Christian Schaefer; Nadjib Schahab; Robert P Finger; Thomas Schultz
Journal:  Sci Rep       Date:  2022-01-26       Impact factor: 4.379

4.  Development and Validation of Retinal Vasculature Nomogram in Suspected Angina Due to Coronary Artery Disease.

Authors:  Pingting Zhong; Jie Qin; Zhixi Li; Lei Jiang; Qingsheng Peng; Manqing Huang; Yingwen Lin; Baoyi Liu; Cong Li; Qiaowei Wu; Yu Kuang; Shirong Cui; Honghua Yu; Zaiyi Liu; Xiaohong Yang
Journal:  J Atheroscler Thromb       Date:  2021-03-19       Impact factor: 4.394

5.  Predicting Systemic Health Features from Retinal Fundus Images Using Transfer-Learning-Based Artificial Intelligence Models.

Authors:  Nergis C Khan; Chandrashan Perera; Eliot R Dow; Karen M Chen; Vinit B Mahajan; Prithvi Mruthyunjaya; Diana V Do; Theodore Leng; David Myung
Journal:  Diagnostics (Basel)       Date:  2022-07-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.